[Drugs in development for the treatment of osteoporosis: Incadronate].
Ohsawa
Minoru
M
Department of Obstetrics and Gynecology, Gunma University School of Medicine.
Soda
Masayuki
M
Mizunuma
Hideki
H
D000818:Animals; D015519:Bone Density; D016723:Bone Remodeling; D002118:Calcium / Q000378:metabolism; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D015775:Fractures, Stress / Q000517:prevention & control; D006801:Humans; D007375:Interleukin-1 / Q000378:metabolism; D010024:Osteoporosis / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D010281:Parathyroid Hormone / Q000378:metabolism; D016103:Spinal Fractures / Q000517:prevention & control
D004164:Diphosphonates; D007375:Interleukin-1; D010281:Parathyroid Hormone; C071542:cimadronate; D002118:Calcium